Streetbeat News

Stock Prices

TEVA

Teva Pharmaceutical's stock is on the rise due to debt reduction, stabilization in generic prices, and new product launches. The company's innovative drugs and biosimilar pipeline, including AUSTEDO and upcoming biosimilars like PROLIA and RANIVISIO, present significant growth opportunities. With substantial biologic patent expirations expected, Teva could experience another boom.

Portfolio Pulse from

December 06, 2024 | 1:15 pm

TSHA

Taysha Gene Therapies has granted a stock option to a new employee under its 2023 Inducement Plan, in line with Nasdaq Listing Rule 5635(c)(4).

Portfolio Pulse from

December 06, 2024 | 1:15 pm

DLTR

Dollar Tree Inc. (NASDAQ: DLTR) is experiencing potential institutional accumulation, which could lead to double-digit returns. This information, now in mainstream media, may be too late for retail investors to act upon.

Portfolio Pulse from

December 06, 2024 | 1:15 pm

LULU

Lululemon's stock has surged as 16 banks have increased their price targets, indicating positive sentiment towards the company's recent performance. The company's strategy of introducing bright colors in its apparel line appears to be successful. However, there is a bearish perspective suggesting selling into the rally.

Portfolio Pulse from

December 06, 2024 | 1:15 pm

PLTK

Playtika Holding Corp. announced that its President and CFO, Craig Abrahams, will participate in investor conferences in Q4 2024. This engagement may provide insights into the company's future strategies and performance.

Portfolio Pulse from

December 06, 2024 | 1:15 pm

CELU

Celularity Inc. reported a significant increase in net product sales, over sevenfold, for the third quarter of 2024 compared to the same period in 2023. The company has also filed its quarterly report, ensuring it is up-to-date with its filings.

Portfolio Pulse from

December 06, 2024 | 1:15 pm

VOD

Vodafone is merging its U.K. operations with Three, aiming to become the largest telecom player in the U.K. This strategic move is expected to improve fundamentals and reduce debt, potentially re-rating the stock, which currently trades near all-time lows.

Portfolio Pulse from

December 06, 2024 | 1:15 pm

NXDT

Egan-Jones, a proxy advisory firm, supports all NexPoint nominees for the UDF IV Board, citing issues with the current board's transparency and shareholder trust. NexPoint's expertise is seen as a valuable addition.

Portfolio Pulse from

December 06, 2024 | 1:15 pm

DOOO

BRP Inc. has announced the renewal of its normal course issuer bid, allowing the company to repurchase up to 3,331,852 subordinate voting shares over the next year, representing about 10% of its public float.

Portfolio Pulse from

December 06, 2024 | 1:15 pm